title: New pathways to control inflammatory responses in adipose tissue.
abstract: Obesity is characterized by the presence of chronic inflammation in adipose tissue, particularly in the visceral compartment, that has been causally linked to development of obesity-associated comorbidities. This link can be either direct or indirect, through induction of insulin resistance. This review summarizes recent evidence on potential pharmacological targets of adipose tissue inflammation, with emphasis on mediators that are being studied for intervention in chronic inflammatory diseases and are therefore viable therapeutical candidates. Specifically, we discuss evidence on the role of the inflammasome and its downstream products as a potential target for anti-inflammatory strategies as well as T regulatory (Treg) cells and mediators involved in the resolution phase of inflammation such as resolvins, protectins, annexin A1 (ANXA1) and galectins as potential targets for novel agonist therapies.
authors: Department of Kinesiology and Nutrition, University of Illinois at Chicago, Chicago, IL 60612, USA.
authors: Rand T
authors: RT
authors: Akasheh
authors: Jingbo
authors: J
authors: Pang
authors: Jason M
authors: JM
authors: York
authors: Giamila
authors: G
authors: Fantuzzi
mesh_terms: D000273:Adipose Tissue / Q000276:immunology*; D000818:Animals; D006801:Humans; D007249:Inflammation / Q000276:immunology; D007962:Leukocytes / Q000276:immunology; D009765:Obesity / Q000276:immunology*; D051192:Receptors, Pattern Recognition / Q000276:immunology
chemical_list: D051192:Receptors, Pattern Recognition
references: Obesity (Silver Spring). 2013 Feb;21(2):310-9
references: 23401338
references: J Pathol. 2009 Jul;218(3):360-9
references: 19334049
references: J Clin Endocrinol Metab. 2010 Mar;95(3):1404-11
references: 20080851
references: J Immunol. 2012 Nov 15;189(10):4705-11
references: 23125426
references: Trends Immunol. 2007 Apr;28(4):176-83
references: 17337246
references: J Immunol. 2012 Sep 1;189(5):2597-605
references: 22844113
references: FASEB J. 2003 Feb;17(2):253-5
references: 12475898
references: FASEB J. 2011 Jul;25(7):2399-407
references: 21478260
references: J Clin Invest. 2003 Dec;112(12):1796-808
references: 14679176
references: Curr Pharm Des. 2008;14(12):1225-30
references: 18473870
references: Science. 2010 Apr 9;328(5975):228-31
references: 20203013
references: FASEB J. 2007 Feb;21(2):325-32
references: 17267386
references: JAMA. 2013 Jan 2;309(1):71-82
references: 23280227
references: Nat Med. 2009 Aug;15(8):930-9
references: 19633656
references: Endocrinology. 2011 Nov;152(11):4039-45
references: 21862613
references: FASEB J. 2009 Jun;23(6):1946-57
references: 19211925
references: PLoS One. 2013;8(2):e57915
references: 23451284
references: Cell. 2010 Mar 19;140(6):821-32
references: 20303873
references: Curr Opin Pharmacol. 2008 Dec;8(6):765-76
references: 18845272
references: Int Rev Psychiatry. 2012 Jun;24(3):176-88
references: 22724639
references: Ann Rheum Dis. 2012 Nov;71(11):1872-80
references: 22562975
references: Diabetes. 2013 Jun;62(6):1945-56
references: 23349501
references: FASEB J. 2007 Apr;21(4):968-75
references: 17215481
references: Nat Rev Immunol. 2009 Jan;9(1):62-70
references: 19104500
references: J Clin Invest. 2006 Nov;116(11):3015-25
references: 17053832
references: Trends Endocrinol Metab. 2011 Jan;22(1):16-23
references: 20888253
references: BMC Nephrol. 2013 Jan 22;14:23
references: 23339460
references: JAMA. 1999 Oct 27;282(16):1568-75
references: 10546697
references: PLoS One. 2011 Jan 26;6(1):e16376
references: 21298111
references: Cell. 2013 Feb 14;152(4):673-84
references: 23415219
references: Diabetes. 2013 Jun;62(6):1932-44
references: 23349493
references: Nature. 2012 Jun 28;486(7404):549-53
references: 22722857
references: Eur J Endocrinol. 2002 Oct;147(4):553-9
references: 12370119
references: Adv Immunol. 2011;109:87-124
references: 21569913
references: Front Immunol. 2012 Nov 27;3:354
references: 23230437
references: J Pathol. 2013 Jan;229(2):250-63
references: 23007838
references: PLoS One. 2013;8(2):e56100
references: 23409132
references: Diabetes. 2012 Feb;61(2):401-8
references: 22228716
references: Cell Metab. 2010 Dec 1;12(6):593-605
references: 21109192
references: Arterioscler Thromb Vasc Biol. 2009 Jun;29(6):831-6
references: 19359660
references: Diabetes. 2011 Nov;60(11):2954-62
references: 21911743
references: Ann N Y Acad Sci. 2012 Apr;1253:80-91
references: 22329844
references: FASEB J. 2013 Jan;27(1):368-78
references: 23038751
references: Proc Natl Acad Sci U S A. 2011 Sep 13;108(37):15324-9
references: 21876127
references: Genome Biol. 2008 Jan 21;9(1):R14
references: 18208606
references: Clin Exp Immunol. 2011 Oct;166(1):1-15
references: 21762124
references: Proc Natl Acad Sci U S A. 2011 Nov 15;108(46):18696-701
references: 21969596